<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    2044721
   </pmid>
   <datecreated>
    <year>
     1991
    </year>
    <month>
     07
    </month>
    <day>
     18
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1991
    </year>
    <month>
     07
    </month>
    <day>
     18
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2007
    </year>
    <month>
     11
    </month>
    <day>
     15
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0902-4441
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       46
      </volume>
      <issue>
       5
      </issue>
      <pubdate>
       <year>
        1991
       </year>
       <month>
        May
       </month>
      </pubdate>
     </journalissue>
     <title>
      European journal of haematology
     </title>
     <isoabbreviation>
      Eur. J. Haematol.
     </isoabbreviation>
    </journal>
    <articletitle>
     Bioavailability of carbonyl iron: a randomized, double-blind study.
    </articletitle>
    <pagination>
     <medlinepgn>
      272-8
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      49 female blood donors with iron-deficiency anemia were treated with equal doses of iron either as carbonyl iron or ferrous sulfate in a randomized, double-blind fashion. The prevalence of side-effects was similar in the two groups. Mean values for hemoglobin concentration, mean corpuscular volume, corrected reticulocyte count, platelet count, serum iron, total iron-binding capacity, transferrin saturation or erythrocyte protoporphyrin did not differ significantly between the two groups throughout the study. After 16 weeks of therapy, the mean increase in hemoglobin iron was similar in both groups (p = 0.2). Estimates of net changes in total body iron suggested that the overall bioavailability of carbonyl iron was high, about 70% that of ferrous sulfate.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Medicine, Cleveland Metropolitan General Hospital, Case Western Reserve University, Ohio.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Devasthali
      </lastname>
      <forename>
       S D
      </forename>
      <initials>
       SD
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Gordeuk
      </lastname>
      <forename>
       V R
      </forename>
      <initials>
       VR
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Brittenham
      </lastname>
      <forename>
       G M
      </forename>
      <initials>
       GM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Bravo
      </lastname>
      <forename>
       J R
      </forename>
      <initials>
       JR
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Hughes
      </lastname>
      <forename>
       M A
      </forename>
      <initials>
       MA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Keating
      </lastname>
      <forename>
       L J
      </forename>
      <initials>
       LJ
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     DENMARK
    </country>
    <medlineta>
     Eur J Haematol
    </medlineta>
    <nlmuniqueid>
     8703985
    </nlmuniqueid>
    <issnlinking>
     0902-4441
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Ferrous Compounds
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Hemoglobins
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Organometallic Compounds
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      11096-37-0
     </registrynumber>
     <nameofsubstance>
      Transferrin
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      13463-40-6
     </registrynumber>
     <nameofsubstance>
      Iron Carbonyl Compounds
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      7439-89-6
     </registrynumber>
     <nameofsubstance>
      Iron
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      7720-78-7
     </registrynumber>
     <nameofsubstance>
      ferrous sulfate
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anemia, Hypochromic
     </descriptorname>
     <qualifiername majortopicyn="N">
      blood
     </qualifiername>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Biological Availability
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ferrous Compounds
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      metabolism
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hemoglobins
     </descriptorname>
     <qualifiername majortopicyn="N">
      analysis
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Iron
     </descriptorname>
     <qualifiername majortopicyn="Y">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Iron Carbonyl Compounds
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Organometallic Compounds
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      metabolism
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Time Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Transferrin
     </descriptorname>
     <qualifiername majortopicyn="N">
      metabolism
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1991
     </year>
     <month>
      5
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1991
     </year>
     <month>
      5
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1991
     </year>
     <month>
      5
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     2044721
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

